drugset / Trial / NCT06608368

A Clinical Study Assessing the Effects of a Marketed Dentifrice on Tooth Sensitivity While Undergoing Tooth Bleaching

NCT06608368

Phase 4 Completed 90 enrolled HALEON
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to investigate the efficacy of a marketed dentifrice containing 5 percent (%) NovaMin (Calcium Sodium Phosphosilicate) to reduce tooth sensitivity during and post tooth bleaching compared to a marketed dentifrice containing 5% potassium nitrate (KNO3) and a marketed regular fluoride-containing dentifrice.

Timeline

Start
2024-10-07
Primary completion
2024-11-15
Completion
2024-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject PHOSPHINE SILANE Other / unclassified 5 %
Comparator Potassium Nitrate Other / unclassified 5 %
Background sodium fluoride Unknown 1040 ppm
Background sodium fluoride Unknown 1100 ppm
Background sodium fluoride Unknown 1150 ppm

Indications